Azzad Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$81.3K Sell
2025
Q1
$88.9K Buy
2024
Q4
$93.5K Sell
2024
Q3
$98.8K Sell
2024
Q2
$119K Sell
2024
Q1
$161K Buy